Viridian Therapeutics (VRDN) Competitors $17.04 -0.09 (-0.53%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$17.05 +0.01 (+0.03%) As of 07/11/2025 04:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VRDN vs. OPCH, RDNT, BTSG, SHC, SGRY, PRVA, CON, WGS, VCYT, and ADUSShould you be buying Viridian Therapeutics stock or one of its competitors? The main competitors of Viridian Therapeutics include Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), Veracyte (VCYT), and Addus HomeCare (ADUS). These companies are all part of the "healthcare" industry. Viridian Therapeutics vs. Its Competitors Option Care Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Privia Health Group Concentra Group Holdings Parent GeneDx Veracyte Addus HomeCare Option Care Health (NASDAQ:OPCH) and Viridian Therapeutics (NASDAQ:VRDN) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership. Is OPCH or VRDN more profitable? Option Care Health has a net margin of 4.12% compared to Viridian Therapeutics' net margin of -102,092.39%. Option Care Health's return on equity of 16.90% beat Viridian Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Option Care Health4.12% 16.90% 7.00% Viridian Therapeutics -102,092.39%-70.61%-44.67% Does the media favor OPCH or VRDN? In the previous week, Option Care Health had 4 more articles in the media than Viridian Therapeutics. MarketBeat recorded 10 mentions for Option Care Health and 6 mentions for Viridian Therapeutics. Option Care Health's average media sentiment score of 1.66 beat Viridian Therapeutics' score of 1.01 indicating that Option Care Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Option Care Health 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Viridian Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable valuation & earnings, OPCH or VRDN? Option Care Health has higher revenue and earnings than Viridian Therapeutics. Viridian Therapeutics is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOption Care Health$5.00B0.98$211.82M$1.2424.10Viridian Therapeutics$300K4,634.31-$269.95M-$3.85-4.43 Do analysts prefer OPCH or VRDN? Option Care Health currently has a consensus price target of $35.50, indicating a potential upside of 18.81%. Viridian Therapeutics has a consensus price target of $37.56, indicating a potential upside of 120.40%. Given Viridian Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Viridian Therapeutics is more favorable than Option Care Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Option Care Health 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88Viridian Therapeutics 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.90 Which has more volatility & risk, OPCH or VRDN? Option Care Health has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500. Comparatively, Viridian Therapeutics has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500. Do insiders and institutionals hold more shares of OPCH or VRDN? 98.1% of Option Care Health shares are held by institutional investors. 0.6% of Option Care Health shares are held by insiders. Comparatively, 1.6% of Viridian Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummaryOption Care Health beats Viridian Therapeutics on 11 of the 16 factors compared between the two stocks. Get Viridian Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VRDN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRDN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRDN vs. The Competition Export to ExcelMetricViridian TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.40B$2.99B$5.61B$9.11BDividend YieldN/A2.39%5.24%4.02%P/E Ratio-4.4320.5827.9620.25Price / Sales4,634.31292.00430.8999.65Price / CashN/A42.8637.4658.16Price / Book2.807.638.045.49Net Income-$269.95M-$55.05M$3.18B$250.27M7 Day Performance9.34%8.54%3.67%4.80%1 Month Performance8.74%5.51%4.09%7.68%1 Year Performance22.68%2.03%29.58%16.36% Viridian Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRDNViridian Therapeutics3.2009 of 5 stars$17.04-0.5%$37.56+120.4%+31.6%$1.40B$300K-4.4350News CoveragePositive NewsOPCHOption Care Health4.5464 of 5 stars$30.91-0.8%$35.50+14.8%+3.2%$5.10B$5.00B22.758,088News CoveragePositive NewsAnalyst ForecastRDNTRadNet4.1827 of 5 stars$55.26-1.7%$69.60+26.0%-7.3%$4.22B$1.83B-128.5111,021Positive NewsAnalyst ForecastBTSGBrightSpring Health Services1.6722 of 5 stars$22.00-0.5%$24.90+13.2%+83.0%$3.89B$11.27B78.5735,000SHCSotera Health3.1488 of 5 stars$11.40-2.9%$16.00+40.4%-3.2%$3.33B$1.10B18.943,000SGRYSurgery Partners2.4527 of 5 stars$22.03-0.5%$33.56+52.3%-13.7%$2.84B$3.11B-14.4015,000PRVAPrivia Health Group4.5054 of 5 stars$21.35-3.4%$27.77+30.1%+14.2%$2.70B$1.74B184.251,140News CoverageAnalyst ForecastCONConcentra Group Holdings Parent2.9378 of 5 stars$20.33-1.1%$28.50+40.2%N/A$2.64B$1.90B15.1711,250News CoverageWGSGeneDx3.839 of 5 stars$85.74-6.4%$90.13+5.1%+141.3%$2.61B$305.45M100.671,200Trending NewsAnalyst ForecastInsider TradeVCYTVeracyte3.5821 of 5 stars$26.34-4.3%$40.90+55.3%+20.0%$2.15B$445.76M64.25790ADUSAddus HomeCare4.9775 of 5 stars$110.62-1.1%$142.57+28.9%-7.4%$2.06B$1.15B24.9749,703Positive News Related Companies and Tools Related Companies OPCH Competitors RDNT Competitors BTSG Competitors SHC Competitors SGRY Competitors PRVA Competitors CON Competitors WGS Competitors VCYT Competitors ADUS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRDN) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viridian Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viridian Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
